CellCept

CellCept is a brand name of mycophenolate mofetil, approved by the FDA in the following formulation(s):

CELLCEPT (mycophenolate mofetil - capsule; oral)

• 
  Manufacturer: ROCHE PALO
  
  Approval date: May 3, 1995
  
  Strength(s): 250MG ^[RLD][AB]

CELLCEPT (mycophenolate mofetil - suspension; oral)

• 
  Manufacturer: ROCHE PALO
  
  Approval date: October 1, 1998
  
  Strength(s): 200MG/ML ^[RLD]

CELLCEPT (mycophenolate mofetil - tablet; oral)

• 
  Manufacturer: ROCHE PALO
  
  Approval date: June 19, 1997
  
  Strength(s): 500MG ^[RLD][AB]

CELLCEPT (mycophenolate mofetil hydrochloride - injectable; injection)

• 
  Manufacturer: ROCHE PALO
  
  Approval date: August 12, 1998
  
  Strength(s): 500MG/VIAL ^[RLD]

Has a generic version of CellCept been approved?

A generic version of CellCept has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to CellCept and have been approved by the FDA:

mycophenolate mofetil capsule; oral

• 
  Manufacturer: ACCORD HLTHCARE INC
  
  Approval date: May 4, 2009
  
  Strength(s): 250MG ^[AB]


• 
  Manufacturer: APOTEX CORP
  
  Approval date: April 22, 2009
  
  Strength(s): 250MG ^[AB]


• 
  Manufacturer: DR REDDYS LABS LTD
  
  Approval date: October 27, 2011
  
  Strength(s): 250MG ^[AB]


• 
  Manufacturer: ENDO PHARMS
  
  Approval date: December 22, 2009
  
  Strength(s): 250MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: May 4, 2009
  
  Strength(s): 250MG ^[AB]


• 
  Manufacturer: ROXANE
  
  Approval date: July 29, 2008
  
  Strength(s): 250MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: October 15, 2008
  
  Strength(s): 250MG ^[AB]


• 
  Manufacturer: STRIDES ARCOLAB LTD
  
  Approval date: June 10, 2010
  
  Strength(s): 250MG ^[AB]


• 
  Manufacturer: TEVA PHARMS
  
  Approval date: May 6, 2009
  
  Strength(s): 250MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA INC
  
  Approval date: May 4, 2009
  
  Strength(s): 250MG ^[AB]

mycophenolate mofetil tablet; oral

• 
  Manufacturer: ACCORD HLTHCARE
  
  Approval date: May 4, 2009
  
  Strength(s): 500MG ^[AB]


• 
  Manufacturer: ALKEM LABS LTD
  
  Approval date: November 4, 2011
  
  Strength(s): 500MG ^[AB]


• 
  Manufacturer: APOTEX
  
  Approval date: April 22, 2009
  
  Strength(s): 500MG ^[AB]


• 
  Manufacturer: ENDO PHARMS
  
  Approval date: July 16, 2010
  
  Strength(s): 500MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: May 4, 2009
  
  Strength(s): 500MG ^[AB]


• 
  Manufacturer: ROXANE
  
  Approval date: July 29, 2008
  
  Strength(s): 500MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: October 15, 2008
  
  Strength(s): 500MG ^[AB]


• 
  Manufacturer: STRIDES ARCOLAB LTD
  
  Approval date: June 10, 2010
  
  Strength(s): 500MG ^[AB]


• 
  Manufacturer: TEVA PHARMS
  
  Approval date: May 4, 2009
  
  Strength(s): 500MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA INC
  
  Approval date: May 4, 2009
  
  Strength(s): 500MG ^[AB]

Note: No generic formulation of the following products are available.

• mycophenolate mofetil - suspension; oral


• mycophenolate mofetil hydrochloride - injectable; injection

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of CellCept. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
  Patent 5,543,408
  Issued: August 6, 1996
  Inventor(s): Fu; Roger C. & Leung; De-Mei & Fleitman; Jeffrey S. & Rizzolio; Michele C. & Miksztal; Andrew R.
  Assignee(s): Syntex (U.S.A.) Inc.
  The crystalline anhydrous salt formed by complexing mycophenolate mofetil with an anion selected from the group chloride, sulfate, phosphate and acetate (in particular the hydrochloride salt), and pharmaceutical compositions, intravenous formulations and a kit thereof, and associated methods of treatment.
  
  Patent expiration dates:
  
  
  • September 15, 2013
    
    ✓ 
    Drug product
  
  



• 
  Mycophenolate mofetil high dose oral suspensions
  Patent 5,688,529
  Issued: November 18, 1997
  Inventor(s): Lidgate; Deborah Marilyn & Wang-Kessler; Li-hua & Joshi; Bindu & Hegde; Sayee Gojanan & Gu; Leo
  Assignee(s): Syntex (U.S.A) Inc.
  High dose, dry granulations or powder blends and aqueous oral suspensions of mycophenolate mofetil or mycophenolic acid, contain: active compound (7.5-30%), suspending/viscosity agent, sweetener, flavor, buffer (to a pH of 5-7.5), and optionally contain flavor enhancer, wetting agent, antimicrobial agent and color.
  
  Patent expiration dates:
  
  
  • November 18, 2014
    
    ✓ 
    Drug product
  
  

See also...

• Cellcept Consumer Information (Drugs.com)
• CellCept Consumer Information (Wolters Kluwer)
• CellCept Capsules Consumer Information (Wolters Kluwer)
• CellCept Solution Consumer Information (Wolters Kluwer)
• CellCept Suspension Consumer Information (Wolters Kluwer)
• CellCept Consumer Information (Cerner Multum)
• Cellcept Advanced Consumer Information (Micromedex)
• Cellcept Oral Advanced Consumer Information (Micromedex)
• Mycophenolate Mofetil Consumer Information (Wolters Kluwer)
• Mycophenolate Mofetil Capsules Consumer Information (Wolters Kluwer)
• Mycophenolate Mofetil Solution Consumer Information (Wolters Kluwer)
• Mycophenolate Mofetil Suspension Consumer Information (Wolters Kluwer)
• Mycophenolate mofetil Consumer Information (Cerner Multum)
• Mycophenolate Intravenous Advanced Consumer Information (Micromedex)
• Mycophenolate mofetil Advanced Consumer Information (Micromedex)
• Mycophenolate mofetil Oral, Intravenous Advanced Consumer Information (Micromedex)
• Mycophenolate AHFS DI Monographs (ASHP)